Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2005 2
2006 2
2007 2
2008 1
2011 3
2012 3
2013 2
2014 6
2016 3
2017 1
2018 2
2019 3
2020 2
2021 4
2022 5
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of Malignant Peritoneal Mesothelioma.
Levý M, Boublíková L, Büchler T, Šimša J. Levý M, et al. Klin Onkol. 2019 Fall;32(5):333-337. doi: 10.14735/amko2019333. Klin Onkol. 2019. PMID: 31610664 Review. English.
Malignant mesothelioma is a highly malignant disease that most often occurs in the pleura of the thoracic cavity, followed by the peritoneum, pericardium, or tinea vaginalis testis. Malignant peritoneal mesothelioma (MPM) accounts for 10- …
Malignant mesothelioma is a highly malignant disease that most often occurs in the pleura of the thoracic cavity, follo …
Peritoneal cancer treatment.
Yonemura Y, Canbay E, Endou Y, Ishibashi H, Mizumoto A, Miura M, Li Y, Liu Y, Takeshita K, Ichinose M, Takao N, Hirano M, Sako S, Tsukiyama G. Yonemura Y, et al. Expert Opin Pharmacother. 2014 Apr;15(5):623-36. doi: 10.1517/14656566.2014.879571. Expert Opin Pharmacother. 2014. PMID: 24617975 Review.
INTRODUCTION: In the past, peritoneal surface malignancy (PSM) was considered as a final stage of cancer, and patients were offered the best supportive care. ...EXPERT OPINION: Recent studies show that CRS plus intraperitoneal chemotherapy applications confer prolon …
INTRODUCTION: In the past, peritoneal surface malignancy (PSM) was considered as a final stage of cancer, and patients were offered t …
Principles of Surgical Management of Peritoneal Mesothelioma.
Steadman JA, Grotz TE. Steadman JA, et al. J Natl Compr Canc Netw. 2023 Sep;21(9):981-986. doi: 10.6004/jnccn.2023.7055. J Natl Compr Canc Netw. 2023. PMID: 37673112 Review.
Malignant peritoneal mesothelioma (MPeM) is a rare malignancy and represents 5% to 30% of malignant mesothelioma cases. ...Those with biphasic histology, bicavitary disease, and metastatic lymphadenopathy may be considered for surgery following …
Malignant peritoneal mesothelioma (MPeM) is a rare malignancy and represents 5% to 30% of malignant mesotheli …
Pathohistological diagnosis and differential diagnosis.
Tischoff I, Neid M, Neumann V, Tannapfel A. Tischoff I, et al. Recent Results Cancer Res. 2011;189:57-78. doi: 10.1007/978-3-642-10862-4_5. Recent Results Cancer Res. 2011. PMID: 21479896 Review.
Other possible risk factors are radiation, recurrent pleuritis/peritonitis and simian virus 40 (SV 40).Malignant pleural mesothelioma is most common, whereas malignant peritoneal mesothelioma accounts only for 6-10%. ...Epithelioid type is the m …
Other possible risk factors are radiation, recurrent pleuritis/peritonitis and simian virus 40 (SV 40).Malignant pleural mesotheli …
Current Management and Future Opportunities for Peritoneal Metastases: Peritoneal Mesothelioma.
Alexander HR Jr, Li CY, Kennedy TJ. Alexander HR Jr, et al. Ann Surg Oncol. 2018 Aug;25(8):2159-2164. doi: 10.1245/s10434-018-6337-5. Epub 2018 Feb 8. Ann Surg Oncol. 2018. PMID: 29423664 Review.
PURPOSE: Diffuse malignant peritoneal mesothelioma (MPM) is a rare and ultimately fatal cancer that was first described just over a century ago. ...Studies on the molecular biology of MPM have yielded new insights relating to the potentially important role of …
PURPOSE: Diffuse malignant peritoneal mesothelioma (MPM) is a rare and ultimately fatal cancer that was first described …
Consensus statement on peritoneal mesothelioma.
Deraco M, Bartlett D, Kusamura S, Baratti D. Deraco M, et al. J Surg Oncol. 2008 Sep 15;98(4):268-72. doi: 10.1002/jso.21055. J Surg Oncol. 2008. PMID: 18726890 Review.
Diffuse malignant peritoneal mesothelioma (DMPM) has been traditionally regarded as a rapidly lethal disease. ...A questionnaire was placed on the website of the "5(th) International Workshop on Peritoneal Surface Malignancies" and the group members vo …
Diffuse malignant peritoneal mesothelioma (DMPM) has been traditionally regarded as a rapidly lethal disease. ...A ques …
Advances in the management of peritoneal mesothelioma.
Raza A, Huang WC, Takabe K. Raza A, et al. World J Gastroenterol. 2014 Sep 7;20(33):11700-12. doi: 10.3748/wjg.v20.i33.11700. World J Gastroenterol. 2014. PMID: 25206274 Free PMC article. Review.
Malignant peritoneal mesothelioma (PM) is an infrequent disease which has historically been associated with a poor prognosis. ...Accordingly, an increasing interest in identifying molecular targets and developing targeted therapies is emerging. Among s …
Malignant peritoneal mesothelioma (PM) is an infrequent disease which has historically been associated with a poor prog …
Malignant Peritoneal Mesothelioma: Treatment Options and Survival.
Salo SAS, Ilonen I, Laaksonen S, Myllärniemi M, Salo JA, Rantanen T. Salo SAS, et al. Anticancer Res. 2019 Feb;39(2):839-845. doi: 10.21873/anticanres.13183. Anticancer Res. 2019. PMID: 30711965
BACKGROUND: Malignant peritoneal mesothelioma (MPeM) is a rare type of cancer with a poor prognosis. ...
BACKGROUND: Malignant peritoneal mesothelioma (MPeM) is a rare type of cancer with a poor prognosis. ...
Treatment of Platinum Nonresponsive Metastatic Malignant Peritoneal Mesothelioma With Combination Chemoimmunotherapy.
Foote MB, Shia J, Zauderer MG, Nash GM, Cercek A. Foote MB, et al. J Immunother. 2022 Feb-Mar 01;45(2):100-103. doi: 10.1097/CJI.0000000000000399. J Immunother. 2022. PMID: 34723916 Free PMC article.
Malignant peritoneal mesothelioma is a rare cancer associated with minimal durable disease control with chemotherapy and poor overall survival. The efficacy of combined cytotoxic chemotherapy and immune checkpoint inhibitors (ICIs) in malignant peri …
Malignant peritoneal mesothelioma is a rare cancer associated with minimal durable disease control with chemotherapy an …
Diffuse malignant peritoneal mesothelioma--an update on treatment.
Mirarabshahii P, Pillai K, Chua TC, Pourgholami MH, Morris DL. Mirarabshahii P, et al. Cancer Treat Rev. 2012 Oct;38(6):605-12. doi: 10.1016/j.ctrv.2011.10.006. Epub 2011 Nov 21. Cancer Treat Rev. 2012. PMID: 22104079 Review.
Mesotheliomas are aggressive and lethal neoplasms arising from mesothelial cells lining the pleura, peritoneum, tunica vaginalis testis and pericardium. Malignant peritoneal mesothelioma accounts for about 30% of all mesotheliomas. ...Due to peritoneal …
Mesotheliomas are aggressive and lethal neoplasms arising from mesothelial cells lining the pleura, peritoneum, tunica vaginalis testis and …
42 results